First Allied Advisory Services Inc. lessened its holdings in Zoetis Inc (NYSE:ZTS) by 9.5% in the 1st quarter, HoldingsChannel reports. The firm owned 4,345 shares of the company’s stock after selling 455 shares during the quarter. First Allied Advisory Services Inc.’s holdings in Zoetis were worth $441,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Farmers & Merchants Trust Co of Chambersburg PA acquired a new position in Zoetis in the first quarter worth about $25,000. Berman Capital Advisors LLC acquired a new position in Zoetis in the fourth quarter worth about $26,000. Athena Capital Advisors LLC acquired a new position in Zoetis in the fourth quarter worth about $29,000. Resources Investment Advisors Inc. acquired a new position in Zoetis in the fourth quarter worth about $31,000. Finally, Lavaca Capital LLC acquired a new position in Zoetis in the fourth quarter worth about $32,000. 90.78% of the stock is owned by hedge funds and other institutional investors.

In other news, insider Roxanne Lagano sold 2,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $101.89, for a total transaction of $203,780.00. Following the sale, the insider now directly owns 30,727 shares of the company’s stock, valued at $3,130,774.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Juan Ramon Alaix sold 312,109 shares of the stock in a transaction that occurred on Thursday, February 28th. The shares were sold at an average price of $94.06, for a total transaction of $29,356,972.54. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 447,975 shares of company stock valued at $42,728,902. Company insiders own 0.29% of the company’s stock.

NYSE ZTS opened at $102.94 on Thursday. The company has a market cap of $48.81 billion, a PE ratio of 32.89, a PEG ratio of 2.55 and a beta of 0.91. The company has a debt-to-equity ratio of 2.84, a current ratio of 4.05 and a quick ratio of 2.79. Zoetis Inc has a 1-year low of $78.90 and a 1-year high of $103.97.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.88 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.09. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.45 billion. Zoetis had a net margin of 23.47% and a return on equity of 73.66%. The company’s revenue was up 6.5% on a year-over-year basis. During the same quarter last year, the business posted $0.75 earnings per share. Equities analysts predict that Zoetis Inc will post 3.48 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 3rd. Stockholders of record on Friday, July 19th will be issued a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Thursday, July 18th. Zoetis’s payout ratio is 21.09%.

Several research analysts recently issued reports on ZTS shares. Zacks Investment Research raised shares of Zoetis from a “hold” rating to a “buy” rating and set a $113.00 price target for the company in a research report on Friday, April 19th. Stifel Nicolaus raised shares of Zoetis from a “hold” rating to a “buy” rating and increased their price target for the stock from $97.00 to $110.00 in a research report on Monday, March 4th. SunTrust Banks started coverage on shares of Zoetis in a research report on Tuesday, March 19th. They issued a “hold” rating and a $100.00 price target for the company. Gabelli lowered shares of Zoetis from a “buy” rating to a “hold” rating and set a $108.00 price objective for the company. in a report on Thursday, May 2nd. They noted that the move was a valuation call. Finally, BMO Capital Markets raised their price objective on shares of Zoetis from $101.00 to $105.00 and gave the stock a “market perform” rating in a report on Thursday, May 9th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Zoetis currently has a consensus rating of “Buy” and an average price target of $103.15.

WARNING: This article was originally published by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/first-allied-advisory-services-inc-sells-455-shares-of-zoetis-inc-zts/3019426.html.

About Zoetis

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Featured Article: Should I follow buy, hold and sell recommendations?

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.